English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

People who use drugs are badly affected by chronic hepatitis C. As a result of the pragmatic national drug policy in Switzerland, the majority of persons with an opioid dependency are on opioid agonist therapy (OAT) and therefore in the healthcare system. For years, national guidelines have recommended that all OAT patients be regularly tested for hepatitis C and, if tested positive, referred for treatment.

Hepatitis C micro-elimination among people on opioid agonist therapy is a low-hanging fruit